Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NADOLOL 80 MG TABLET

NADOLOL
$0.2958per EA

Strength

80 mg/1

Manufacturer

Alembic Pharmaceuticals Inc.

NDC

62332040431

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

NADOLOL

Approval Type

Generic (ANDA)

FDA Application

ANDA211763

On Market Since

6/8/2023

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

+0.4%

3M

+9.7%

6M

+4.0%

1Y

+3.9%

3Y

N/A

5Y

N/A

All

-38.8%

Generic Alternatives

1 alternative • Same active ingredient

NADOLOL 80 MG TABLET
Generic
72664021301•VGYAAN Pharmaceuticals LLC
$0.5944
+101% more

Related Drugs

Same classification

METOPROLOL TARTRATE 25 MG TAB
Generic
00378001801•Mylan Pharmaceuticals Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
00378001805•Mylan Pharmaceuticals Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
51079025520•Mylan Institutional LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817025000•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817025010•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817036000•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
52817036010•TruPharma LLC
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
57237010001•Rising Pharma Holdings Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
57237010099•Rising Pharma Holdings Inc.
$0.0171
per EA
METOPROLOL TARTRATE 25 MG TAB
Generic
62332011231•Alembic Pharmaceuticals Inc.
$0.0171
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy